Home › Targets › IL-2

IL-2 (2 companies · 4 programs)

Companies with an active program directed at IL-2.

Medicenna Therapeutics Corp. MDNAF

MDNA11 — Solid Tumors Phase 1
MDNA11 — Melanoma Phase 1
MDNA113 Preclinical

Cue Biopharma, Inc. CUE

CUE-401 Preclinical